Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID Reference, 4th edition, 372 pages

+ the daily Top 10


  Prostate Cancer

  Free Subscription


18.05.2020

2 BMC Cancer
1 Cancer
1 Cancer Res
9 Eur Urol
1 Hum Pathol
2 Int J Cancer
1 Int J Radiat Oncol Biol Phys
1 J Cell Physiol
1 J Clin Oncol
1 J Nucl Med
9 J Urol
1 JAMA
1 Mod Pathol
2 PLoS One
1 Prostate
1 Radiology
3 Urol Int
1 Urology


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    BMC Cancer

  1. DE BRUYCKER A, Spiessens A, Dirix P, Koutsouvelis N, et al
    PEACE V - Salvage Treatment of OligoRecurrent nodal prostate cancer Metastases (STORM): a study protocol for a randomized controlled phase II trial.
    BMC Cancer. 2020;20:406.
    PubMed         Abstract available

  2. QIU C, Bai Y, Yin T, Miao X, et al
    Targeted imaging of orthotopic prostate cancer by using clinical transformable photoacoustic molecular probe.
    BMC Cancer. 2020;20:419.
    PubMed         Abstract available


    Cancer

  3. PRINTZ C
    First person profile: Maha Hussain, MD: Dr. Hussain's contributions to research on prostate cancer have led to major treatment advances.
    Cancer. 2020;126:2507-2508.
    PubMed        


    Cancer Res

  4. HARLEMON M, Ajayi O, Kachambwa P, Kim MS, et al
    A custom genotyping array reveals population-level heterogeneity for the genetic risks of prostate cancer and other cancers in Africa.
    Cancer Res. 2020 May 11. pii: 0008-5472.CAN-19-2165.
    PubMed         Abstract available


    Eur Urol

  5. LA TAILLE A, Ingels A
    Re: Systematic Review of Systemic Therapies and Therapeutic Combinations with Local Treatments for High-risk Localized Prostate Cancer.
    Eur Urol. 2020 May 10. pii: S0302-2838(20)30244.
    PubMed        

  6. ZELIC R, Garmo H, Zugna D, Stattin P, et al
    Corrigendum re "Predicting Prostate Cancer Death with Different Pretreatment Risk Stratification Tools: A Head-to-head Comparison in a Nationwide Cohort Study" [Eur Urol 2020;77:180-8].
    Eur Urol. 2020 May 5. pii: S0302-2838(20)30191.
    PubMed        

  7. CHESNUT GT, Vertosick EA, Ehdaie B
    Reply to Jianhui Du, Yueguang Liu, and Weigang Yan's Letter to the Editor re: Gregory T. Chesnut, Emily A. Vertosick, Nicole Benfante, et al. Role of Changes in Magnetic Resonance Imaging or Clinical Stage in Evaluation of Disease Progression for Men
    Eur Urol. 2020 May 5. pii: S0302-2838(20)30318.
    PubMed        

  8. RODRIGUEZ SANCHEZ L, Macek P, Barbe Y, Cathelineau X, et al
    Re: MRI-Targeted, Systematic, and Combined Biopsy for Prostate Cancer Diagnosis.
    Eur Urol. 2020 May 6. pii: S0302-2838(20)30254.
    PubMed        

  9. VILLERS A, Olivier J
    Re: Long-term Outcomes of Active Surveillance for Prostate Cancer: The Memorial Sloan Kettering Cancer Center Experience.
    Eur Urol. 2020 May 7. pii: S0302-2838(20)30235.
    PubMed        

  10. DARST BF, Wan P, Sheng X, Bensen JT, et al
    A Germline Variant at 8q24 Contributes to Familial Clustering of Prostate Cancer in Men of African Ancestry.
    Eur Urol. 2020 May 11. pii: S0302-2838(20)30328.
    PubMed         Abstract available

  11. WALZ J
    Re: Prostate-specific Membrane Antigen Ligand Positron Emission Tomography in Men with Nonmetastatic Castration-resistant Prostate Cancer.
    Eur Urol. 2020 May 7. pii: S0302-2838(20)30237.
    PubMed        

  12. VICKERS A, Carlsson SV, Cooperberg M
    Routine Use of Magnetic Resonance Imaging for Early Detection of Prostate Cancer Is Not Justified by the Clinical Trial Evidence.
    Eur Urol. 2020 May 7. pii: S0302-2838(20)30248.
    PubMed         Abstract available

  13. ZLOTTA AR, Sadeghian A
    Re: Artificial Intelligence for Diagnosis and Grading of Prostate Cancer in Biopsies: A Population-based, Diagnostic Study.
    Eur Urol. 2020 May 7. pii: S0302-2838(20)30242.
    PubMed        


    Hum Pathol

  14. HEAPHY CM, Haffner MC, Graham MK, Lim D, et al
    Telomere lengths differ significantly between small cell neuroendocrine prostate carcinoma and adenocarcinoma of the prostate.
    Hum Pathol. 2020 May 7. pii: S0046-8177(20)30086.
    PubMed         Abstract available


    Int J Cancer

  15. REMMERS S, Roobol MJ
    Personalized strategies in population screening for prostate cancer.
    Int J Cancer. 2020 May 11. doi: 10.1002/ijc.33045.
    PubMed         Abstract available

  16. MEYERS TJ, Weiner AB, Graff RE, Desai AS, et al
    Association between inflammatory bowel disease and prostate cancer: A large-scale, prospective, population-based study.
    Int J Cancer. 2020 May 13. doi: 10.1002/ijc.33048.
    PubMed         Abstract available


    Int J Radiat Oncol Biol Phys


  17. Erratum to: Liu W, Zukotynski K, Emmett L, Chung HT, Chung P, Wolfson R, Rachinsky I, Kapoor A, Metser U, Loblaw A, Morton G, Sexton T, Lock M, Helou J, Berlin A, Boylan C, Archer S, Pond GR, Bauman G. A Prospective Study of 18F-DCFPyL PSMA PET/CT Res
    Int J Radiat Oncol Biol Phys. 2020;107:390.
    PubMed        


    J Cell Physiol

  18. GUAN H, Peng R, Fang F, Mao L, et al
    Tumor-associated macrophages promote prostate cancer progression via exosome-mediated miR-95 transfer.
    J Cell Physiol. 2020 May 14. doi: 10.1002/jcp.29784.
    PubMed         Abstract available


    J Clin Oncol

  19. JACKSON WC, Hartman HE, Dess RT, Birer SR, et al
    Addition of Androgen-Deprivation Therapy or Brachytherapy Boost to External Beam Radiotherapy for Localized Prostate Cancer: A Network Meta-Analysis of Randomized Trials.
    J Clin Oncol. 2020 May 12:JCO1903217. doi: 10.1200/JCO.19.03217.
    PubMed         Abstract available


    J Nucl Med

  20. HARSINI S, Saprunoff H, Alden TM, Mohammadi B, et al
    The effects of monosodium glutamate on PSMA radiotracer uptake in men with recurrent prostate cancer: a prospective, randomized, double-blind, placebo-controlled intra-individual imaging study.
    J Nucl Med. 2020 May 8. pii: jnumed.120.246983. doi: 10.2967/jnumed.120.246983.
    PubMed         Abstract available


    J Urol

  21. STOLZENBACH LF, Rosiello G, Deuker M, Colla-Ruvolo C, et al
    The Impact of Race and Age on Distribution of Metastases in Patients with Prostate Cancer.
    J Urol. 2020 May 12:101097JU0000000000001131. doi: 10.1097/JU.0000000000001131.
    PubMed         Abstract available

  22. ATALA A
    Re: Galpha-13 Induces C X C Motif Chemokine Ligand 5 Expression in Prostate Cancer Cells by Transactivating NF-kappaB.
    J Urol. 2020 May 12:101097JU000000000000111702.
    PubMed        

  23. GRIEBLING TL
    Re: Low-Value Prostate Cancer Screening among Older Men within the Veterans Health Administration.
    J Urol. 2020 May 13:101097JU0000000000001102. doi: 10.1097/JU.0000000000001102.
    PubMed        

  24. GRIEBLING TL
    Re: Osteoporosis and Prostate Cancer; A 24-Month Prospective Observational Study during Androgen Deprivation Therapy.
    J Urol. 2020 May 13:101097JU000000000000110203.
    PubMed        

  25. GRIEBLING TL
    Re: Patients with Prostate Cancer and Androgen Deprivation Therapy Have Increased Risk of Fractures-A Study from the Fractures and Fall Injuries in the Elderly Cohort (FRAILCO).
    J Urol. 2020 May 13:101097JU000000000000110202.
    PubMed        

  26. GRIEBLING TL
    Re: Do Canadian Radiation Oncologists Consider Geriatric Assessment in the Decision-Making Process for Treatment of Patients 80 Years and Older with Non-Metastatic Prostate Cancer? National Survey.
    J Urol. 2020 May 13:101097JU000000000000110201.
    PubMed        

  27. TANEJA SS
    Re: Prostate Cancer Mortality and Metastasis under Different Biopsy Frequencies in North American Active Surveillance Cohorts.
    J Urol. 2020 May 13:101097JU000000000000111501.
    PubMed        

  28. TANEJA SS
    Re: Influence of the Facility Caseload on the Subsequent Survival of Men with Localized Prostate Cancer Undergoing Radical Prostatectomy.
    J Urol. 2020 May 13:101097JU000000000000111502.
    PubMed        

  29. TANEJA SS
    Re: Utility of Multiparametric Magnetic Resonance Imaging in the Risk Stratification of Men with Grade Group 1 Prostate Cancer on Active Surveillance.
    J Urol. 2020 May 13:101097JU0000000000001115. doi: 10.1097/JU.0000000000001115.
    PubMed        


    JAMA

  30. ABBASI J
    PET-CT Improved High-risk Prostate Cancer Staging in Trial.
    JAMA. 2020;323:1764.
    PubMed        


    Mod Pathol

  31. RACITI P, Sue J, Ceballos R, Godrich R, et al
    Novel artificial intelligence system increases the detection of prostate cancer in whole slide images of core needle biopsies.
    Mod Pathol. 2020 May 11. pii: 10.1038/s41379-020-0551.
    PubMed         Abstract available


    PLoS One

  32. BRASIL DA COSTA FH, Lewis MS, Truong A, Carson DD, et al
    SULF1 suppresses Wnt3A-driven growth of bone metastatic prostate cancer in perlecan-modified 3D cancer-stroma-macrophage triculture models.
    PLoS One. 2020;15:e0230354.
    PubMed         Abstract available

  33. CHAURASIYA S, Widmann S, Botero C, Lin CY, et al
    Estrogen receptor beta exerts tumor suppressive effects in prostate cancer through repression of androgen receptor activity.
    PLoS One. 2020;15:e0226057.
    PubMed         Abstract available


    Prostate

  34. LIU Z, Murphy SF, Huang J, Zhao L, et al
    A novel immunocompetent model of metastatic prostate cancer-induced bone pain.
    Prostate. 2020 May 14. doi: 10.1002/pros.23993.
    PubMed         Abstract available


    Radiology

  35. TAN N, Oyoyo U, Bavadian N, Ferguson N, et al
    PSMA-targeted Radiotracers versus (18)F Fluciclovine for the Detection of Prostate Cancer Biochemical Recurrence after Definitive Therapy: A Systematic Review and Meta-Analysis.
    Radiology. 2020 May 12:191689. doi: 10.1148/radiol.2020191689.
    PubMed         Abstract available


    Urol Int

  36. WESTHOFF N, Ritter M, Maros M, Rassweiler-Seyfried MC, et al
    Prospective Feasibility Study of Single-Shot Antibiotic Prophylaxis in Transrectal Focal Ablation of Prostate Cancer.
    Urol Int. 2020 May 12:1-8. doi: 10.1159/000507123.
    PubMed         Abstract available

  37. HENNENLOTTER J, Neumann T, Perner S, Wagner V, et al
    Impact of Histopathological Prostate Inflammation on Urine-Based Prostate Cancer Prediction Using the Prostate Cancer Gene 3 Score.
    Urol Int. 2020 May 8:1-6. doi: 10.1159/000506885.
    PubMed         Abstract available

  38. SAWAZAKI H, Kitamura Y, Yagi K, Arai Y, et al
    Impact of Androgen Deprivation Therapy on Non-Alcoholic Fatty Liver Disease in Patients with Prostate Cancer: A CT Evaluation.
    Urol Int. 2020 May 12:1-6. doi: 10.1159/000507351.
    PubMed         Abstract available


    Urology

  39. NOSE BD, Boysen WR, Kahokehr AA, Inouye BM, et al
    Extirpative cultures reveal infectious pubic bone osteomyelitis in prostate cancer survivors with urinary-pubic symphysis fistulae (UPF).
    Urology. 2020 May 7. pii: S0090-4295(20)30520.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Prostate Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: